More Beat Up Blue Chips
Recently we highlighted several best-of-breed large capitalization companies that have materially under performed this year. Another three companies are examined below. These are not speculative names. They are not richly valued technology or consumer discretionary stocks either. They have wide defensive moats and should be beneficiary of strong cyclical and secular uptrend. But they under performed enough during 2021 with Read more ➝
Beaten Down Blue Chips
Several high quality companies now sell for discounted prices after the strong sell since Thanksgiving. The main US indexes maintain relatively high sales and earnings multiples historically. This masks the damage done to most small stocks and even some blue chip names that most astute investors continually monitor for buying opportunities. We highlight three stocks Read more ➝
Friday Investment Talk: Value Vs Growth, Pharma, Stock Picks
Value stocks have been on a tear, while growth stocks and tech leaders have taken a back seat since late January. This has pressured the overall market indexes, e.g. the S&P 500 and the Nasdaq. March volatility arrived as promised and next week could exacerbate into more weakness as put-call ratios continue to rise and Read more ➝
Market Timing: Reasons To Book Profits
Certain market indicators are at levels of extreme bullishness. The run up in value stocks since the US elections has been shocking. Now is a good time to lighten up on bullish bets.
Trade Idea: Not Losing Face!
The move from Growth stocks to Value names has been quick and decisive. We look at a big name tech stock to take advantage of a rotation back into growth.